Skip to content

Validated Automated Cuff Blood Pressure Devices for Children: STRIDE BP Report and Call to Action.

Jul 2026 · HYPERTENSION · 0 citations · 30 references
Medicine

TL;DR

There is an urgent need for more automated BP devices to be validated in children as there is a severe shortage of validated automated BP device models for children.

Abstract

Background

Similar to adults, in children automated cuff devices are recommended for office, home, and ambulatory blood pressure (BP) measurement. However, a device validated in adults may not be accurate in children, and separate investigation is necessary. Moreover, current pediatric guidelines recommend hypertension detected by an automated device to be confirmed using auscultation. The evidence on validated automated BP devices for children (aged 3-12 years) is presented.

Methods

STRIDE BP (Science and Technology for Regional Innovation and Development in Europe-Blood Pressure; www.stridebp.org) performs periodic systematic PubMed searches for validation studies of automated BP devices. The data set of studies including children was analyzed.

Results

Fifty-one of 628 studies in the STRIDE BP database included children. Forty-one (80%) concluded that the test device passed the validation, yet due to protocol violations, STRIDE BP approved 22 of them (43%). These 22 studies validated 20 devices (14 on the market). Seven additional devices had measurement functions equivalent to STRIDE BP-approved devices (6 on the market). Meta-analysis of 20 successful studies including children and older individuals (N=1476) showed a pooled test-reference systolic BP difference of 0.6 mm Hg (95% CI, -0.2 to 1.4), and diastolic -0.3 (95% CI, -1.2 to 0.6). Meta-analysis of 7 studies including only children (N=410) showed a pooled difference of 1.0 (95% CI, -0.7 to 2.8)/-1.3 (95% CI, -2.9 to 0.4) mm Hg.

Conclusions

There is a severe shortage of validated automated BP device models for children, with published studies often having methodological issues. Some devices are validated in children and, as in adults, can replace auscultatory devices for office hypertension diagnosis. There is an urgent need for more automated BP devices to be validated in children.

View source

Similar papers

Review Open access Jul 2026

Current state of blood pressure measurement in pregnant people in Canada: A national, inter-disciplinary survey.

The most concerning finding is failure to use and recommend devices validated in pregnancy for pregnant people, due at least in part, to the limited number of devices validated for this population.

L. Dubrofsky, Sachin V. Pasricha, John W. Snelgrove et al. · 0 citations
Review Open access Jul 2026

Device-related differences in blood pressure measurement and their impact on hypertension prevalence in children and adolescents.

Despite modest underestimation of DBP in specific subgroups, oscillometric BP measurement showed acceptable agreement with the auscultatory method and yielded similar hypertension prevalence estimates, suggesting that oscillometric devices may be useful for pediatric BP measurement in public health surveillance systems...

Sung Hye Kim, Yu-Mi Kim, Hack-Lyoung Kim et al. · 0 citations
Review Aug 2026

Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.

More research is needed to establish the accuracy and clinical utility of these novel devices and their role in improving the diagnosis and management of hypertension.

G. Stergiou, A. Menti, Kei Asayama et al. · 0 citations
Review Open access Aug 2026

Wearable, cuffless, and portable devices for blood pressure monitoring (2015–2025): a scoping review of technologies, calibration, clinical validation, and regulatory frameworks

The 2015–2025 ecosystem shows rapid progress and a transition toward cuffless-specific validation, however, clinical utility depends on intended use, population, calibration/recalibration, and setting, and performance should not be extrapolated across technologies, populations, or contexts.

J. C. Bustamante-Rodríguez, Jhosmer Ballena-Caicedo, Julio César Bautista-Zuta et al. · 0 citations
#software testing Open access Aug 2026

Evaluation of Alysis-001 cuffless blood pressure estimation algorithm against the European Society of Hypertension awake/asleep test criteria in hypertensive patients.

This represents the first evaluation of a Device Type 3 cuffless blood pressure algorithm (automated, wearable, demographic-calibrated, not at heart level) meeting ESH awake/asleep test criteria, suggesting Alysis-001's potential as a clinically viable alternative for ambulatory blood pressure monitoring in hypertensiv...

K. Hongyo, Atsushi Hirayama, Kosuke Shimizu et al. · 0 citations
Aug 2026

Validation of the Arm-Type Fully Automatic Blood Pressure Monitor DBP-62F4B-P in adolescents and adults according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018+Amd 2:2024) standard.

The Arm-Type Fully Automatic Blood Pressure Monitor (model: DBP-62F4B-P) meets the accuracy and consistency requirements of the AAMI/ESH/ISO standard for SBP and DBP measurement in adolescents and adults with arm circumference 22.0-42.0 cm and is suitable for home use based on its design features and validation perform...

Xiaojin Guo · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.